Posts by: Iqra Mumal, MSc

Iqra Mumal, MSc

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

March 29, 2018March 29, 2018

CAR T-cell Therapies Deemed Cost-effective for B-cell Cancers in New Report

News

Treatment with chimeric antigen receptor (CAR) T-cell therapies in B-cell cancers, like certain types of lymphoma and leukemia, is associated with an increase in quality-adjusted and overall survival compared to ... Read more

March 15, 2018

Stem Cell Transplants Bring Long-term Benefits to Relapsed Follicular Lymphoma Patients

News

Results from a recent large-scale study indicate that stem cell transplants should be considered for the treatment of patients with relapsed follicular lymphoma. The study, “Allogeneic Hematopoietic Stem Cell Transplantation ... Read more

March 5, 2018March 5, 2018

Stem Cell Transplants Can Benefit Lymphoma Patients Who Fail to Respond to Chemo, Study Shows

News

Stem cell transplants can lead to excellent outcomes in certain B-cell lymphoma patients who failed to respond to chemoimmunotherapy, a study shows. The results apply to patients with primary mediastinal B-cell lymphoma, ... Read more

February 27, 2018

Phase 2 Study of KD025 Shows Encouraging Clinical Response in Patients with Graft-versus-host Disease

News

Treatment with KD025 is safe and effectively reduces the manifestations of graft-versus-host disease in patients receiving steroids for the condition, or whose condition worsened while on steroids, Kadmon Holdings announced. Those findings ... Read more

February 12, 2018February 12, 2018

Gene Sequencing Technique Accurately Detects Cancer-specific Mutations in Lymphoid Tumors

News

Capture hybridization-based sequencing, a gene sequencing technique, is superior for the detection of lymphoid cancer-associated mutations in a panel of 32 genes, a new study shows. This approach, compared to amplicon ... Read more

December 20, 2017December 20, 2017

Key Genes in T-cell Lymphoma Patients Often Missing Agent That Blocks Cancer Signaling, Study Says

News

The tumor suppressor PD-1, which serves as shut-off switch to prevent damaged T-cells from continuing to develop and proliferate, is frequently missing in crucial genes of patients with T-cell lymphomas, a ... Read more

September 1, 2017

Lymphoma Patient’s Brain Tumor Disappeared After She Received JCAR017, Study Reports

News

Juno Therapeutics‘ immunotherapy JCAR017 eliminated a brain tumor in a patient whose lymphoma had spread to her brain, researchers at Massachusetts General Hospital Cancer Center reported. The team wrote about the ... Read more

August 19, 2017August 19, 2017

FDA Approves Besponsa for Acute Lymphoblastic Leukemia

News

Pfizer Inc. announced that the FDA has approved Besponsa (inotuzumab ozogamicin) for treatment of adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). “For adult patients with B-cell ALL whose ... Read more

July 21, 2017

STING Agonists Help Overcome Lymphoma Patients’ Resistance to Rituxan, Study Finds

News

Therapies called STING agonists help overcome the resistance that lymphoma patients develop to monoclonal antibodies such as Rituxan (rituximab), a study reports. The research, “STING Activation Reverses Lymphoma-Mediated Resistance to Antibody ... Read more